Company intelligence / Profile preview
Pell Bio-Med Technology Co., Ltd.
Taipei, Taiwantrpma.org.tw ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Pell Bio-Med Technology is developing advanced cell therapies for oncology and regenerative medicine. Its lead program is a CD19-targeting CAR-T therapy in Phase 2 clinical trials for follicular lymphoma. Other pipeline assets include preclinical programs targeting rheumatoid arthritis, thyroid cancer, and other cancers using various cell-based modalities such as gene-modified ADSCs and anti-mesothelin CAR-T cells. The company also offers commercial products related to tissue practice laboratory infrastructure and stem cell applications.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Cell therapy (including autologous T cell therapy, CAR-T, CAR-NK, CAR-γδT)Adipose-derived stem cells (ADSC)Synthetic peptide
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Pell Bio-Med Technology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pell Bio-Med Technology Co., Ltd..